February 19, 2026:

In this month’s Across the Consortium, The Big Ten Cancer Research Consortium highlights the innovation, discovery, and impact happening across our member institutions. From novel therapies to tools that guide personalized care, this issue highlights the wide-range of research and initiatives across Big Ten Cancer Research Consortium member institutions, all aimed at improving prevention, detection, and treatment for cancer patients. Read More

August 28, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights advances from our member institutions. From featuring groundbreaking research to innovative treatments and patient-centered care, these stories showcase the breadth of discovery driving progress across the Big Ten. Read More

 
July 15, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights examples of discovery and impact from our member institutions. From grant-funded studies and groundbreaking therapies to new cancer center openings and community health outreach, this issue reflects the variety and depth of work advancing cancer research across the Big Ten. Read More

 
June 11, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue showcases groundbreaking discoveries, acts of philanthropy, and leadership that will shape not only the Big Ten Cancer Research Consortium but also the future of cancer research itself. You’ll also find news of cancer conferences, new research facilities, and impactful research advances.
Read More

 
May 22, 2025: In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights a wide range of updates from our member institutions. This issue covers the impact of budget cuts, celebrates distinguished faculty, honors Asian American Pacific Islander Desi Heritage Month, and announces key leadership additions. You’ll also find highlights of media coverage, participation in cancer conferences and forums, recent advances in cancer research and treatment, prevention and recurrence efforts, and the unveiling of new hospital facilities. Read More

April 30, 2025: 

In this month’s Across the Consortium, the Big Ten Cancer Research Consortium spotlights advancements in colorectal cancer research, collaborative efforts in prostate cancer studies, recent research grant recipients, new podcast episodes, lung cancer research and prevention initiatives, brain cancer discoveries, leadership transitions, and the critical role of clinical trials. Read More

March 17, 2025: 

We are thrilled to reintroduce Across the Consortium, a monthly article showcasing the latest news and events from our member institutions. In this edition, we proudly add our newest member, Fred Hutchinson Cancer Center, which serves as the cancer program for UW Medicine—the University of Washington’s health system—joining our consortium of now 16 institutions.

Read More

October 15, 2021:

In this month’s Across the Consortium, the Big Ten Cancer Research Consortium highlights several investigators involved in detecting, decoding, and understanding genetic abnormalities as well as a potential drug target for treating aggressive pancreatic cancer and a tumor cell that may potentially stop tumor cell seeding and block cancer progression in breast cancer. We also feature a married couple at Penn State Cancer Institute that are building a research program using the MRIdian LINAC by Viewray, a Magnetic Res Magnetic Resonance Imaging (MRI)-guided linear accelerator, one of only 18 units currently open in the U.S. Learn about recent appointments, news grants, and more across our member institutions.

Read More

September 16, 2021:

In this month’s Across the Consortium, we share exciting innovations developed by cancer researchers at our member institutions, including a wearable temperature sensor that can detect dangerous complications in hospitalized cancer patients and new dual-mechanism estrogen receptor inhibitors that could support the treatment of estrogen receptor-positive and metastatic breast cancers. We also share recent appointments and publications highlighting faculty at member institutions. See what’s new in this issue of Across the Consortium.

Read More

August 26, 2021:

In this month’s Across the Consortium, cancer investigators, program managers, and administrators share their progress in oncology research and maintaining their excellent standing through NCI-designation and association accreditation. Learn about new tools that may help identify patients who are at high risk of cancer progression and relapse, as well as promising pre-clinical results to treat human estrogen-receptor positive breast cancer and their metastases in bone, brain, liver, and lungs. Also, find out which of our Big Ten Cancer Research Consortium members increased clinical trial enrollment by 167 percent, and minority participation in clinical trials to 56 percent of total enrollment. Read on to discover what’s new across the Big Ten Cancer Research Consortium.

Read More